CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | Bancel Stephane Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −64,928 | 0 | ||
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Option exercise 10b5-1 | +499,246 | $19.15 | $9.6M | 6,687,037 |
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −147,473 | $56.21 | $8.3M | 6,539,564 |
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −124,838 | $56.96 | $7.1M | 6,414,726 |
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −39,891 | $58.12 | $2.3M | 6,374,835 |
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −187,044 | $58.79 | $11.0M | 6,187,791 |
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −370,853 | 187,541 | ||
| 2026-08-05 | Bancel Stephane Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −128,393 | 64,928 | ||
| 2026-07-15 | Hoge Stephen President | Option exercise 10b5-1 | +37,226 | $19.15 | $713K | 1,521,074 |
| 2026-07-15 | Hoge Stephen President | Option exercise 10b5-1 | +16,110 | $19.15 | $309K | 1,537,184 |
| 2026-07-15 | Hoge Stephen President | Sale 10b5-1 | −53,336 | $67.60 | $3.6M | 1,483,848 |
| 2026-07-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,226 | 0 | ||
| 2026-07-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,110 | 0 | ||
| 2026-07-08 | McDonnell Michael R. Director | Grant or award · Stock Option (Right to Buy) | +7,415 | 7,415 | ||
| 2026-07-08 | McDonnell Michael R. Director | Grant or award · Restricted Stock Units | +1,618 | 1,618 | ||
| 2026-07-08 | McDonnell Michael R. Director | Grant or award · Restricted Stock Units | +5,733 | 5,733 | ||
| 2026-07-05 | Banque Soria Ester Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +18,658 | 18,658 | ||
| 2026-07-05 | Banque Soria Ester Chief Commercial Officer | Grant or award · Restricted Stock Units | +38,364 | 38,364 | ||
| 2026-07-02 | Mock James M Chief Financial Officer | Option exercise | +1,452 | 67,139 | ||
| 2026-07-02 | Mock James M Chief Financial Officer | Shares withheld for taxes | −703 | $72.50 | $51K | 66,436 |
Page 4 of 20 · 389 trades